Atlas Trials

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

Clinical trial NCT01013649 · COMPLETED

Trial details

NCT number
NCT01013649
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pancreatic AdenocarcinomaPancreatic Ductal AdenocarcinomaPancreatic Intraductal Papillary-Mucinous NeoplasmStage I Pancreatic Cancer AJCC v6 and v7Stage II Pancreatic Cancer AJCC v6 and v7
Start date
2010-04-05
Primary completion
2023-12-10
Enrollment
546

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.